Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
YM BIOSCIENCES REPORTS 2007 YEAR END OPERATIONAL AND FINANCIAL RESULTS
Date:9/23/2007
rchase of
shares for
cancellation - - (779,909) (1,029,679)
Net proceeds
from issuance
of shares and
warrants - 42,622,618 18,884,120 123,276,729
-------------------------------------------------------------------------
100,607 47,101,370 17,176,506 125,035,054
Investing
activities:
Short-term
deposits,
net 15,881,679 (55,529,720) (14,988,521) (69,530,513)
Proceeds on
sale of
marketable
securities - 2,211 - 1,404,450
Additions to
property and
equipment and
intangible
assets (127,162) (54,791) (27,034) (577,315)
-------------------------------------------------------------------------
15,754,517 (55,582,300) (15,015,555) (68,703,378)
-------------------------------------------------------------------------
Increase
(decrease) in
cash and cash
equivalents 3,112,034 (32,491,222) (10,033,981) (33,919,262)
Net cash assumed
on acquisition - 34,540,166 5,226,447 39,766,613
Cash and cash
equivalents,
beginning of
period 2,735,317 686,373 5,493,907 -
-------------------------------------------------------------------------
Cash and cash
equivalents,
end of
period $ 5,847,351 $ 2,735,317 $ 686,373 $ 5,847,351
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Non-cash
items:
Issuance of
common
shares on
Delex
acquisi-
tion
'/>"/>
| SOURCE YM BioSciences Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
(Date:5/23/2013)... EXTON, Pa. , May 23, 2013 /PRNewswire/ ... leading research and advisory firms for specialized biopharmaceutical ... gastroenterologists, hepatologists, and infectious disease specialists reported that ... warehousing patients (e.g., intentionally delaying treatment) in anticipation ... physicians than six months ago, when only 6 ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy. (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Verenium ... biotechnology company focused on the development and commercialization of ... , Chief Financial Officer, will present at two ... Mr. Black will present at the Second Annual ... at the Grand Hyatt Hotel in New York City. ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( http://www.syncardia.com ... Health Canada and CE (Europe) approved Total Artificial Heart, ... which boasts more than 380,000 visitors annually, is featuring ... by the Freedom® portable driver as part of its ... exhibitions of its kind. , “BodyWorks combines the ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3[0] The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments[0] NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer[0] Verenium To Present At Two Upcoming Conferences[0] SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre
... July 13 Instrumentation Laboratory (IL) today announced it ... recipients at the upcoming Congress for the International Society ... Meeting for the American Association for Clinical Chemistry (AACC), ... IL on July 19-23 respectively. Launched in July ...
... , ROCKVILLE, Md. , July 13 ... PARADIGM trial, a Phase 2 clinical study evaluating MGAWN1, ... with suspected central nervous system infection due to West ... company that develops immunotherapeutics to treat autoimmune disorders, cancer ...
... SYDNEY, July 12 /PRNewswire-Asia/ -- Pharmaxis (ASX: ... to voluntarily de-list from the Nasdaq Global,Market ("Nasdaq"). , ... review of the demand from existing and,potential international investors ... on Nasdaq and the volume of Pharmaxis ADS trading,in ...
Cached Biology Technology:Instrumentation Laboratory to Announce 'Passion & Results' Award Winners 2Instrumentation Laboratory to Announce 'Passion & Results' Award Winners 3MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 2MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 3MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 4Pharmaxis to Voluntarily De-List from Nasdaq 2Instrumentation Laboratory to Announce 'Passion & Results' Award WinnersMacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile VirusPharmaxis to Voluntarily De-List from Nasdaq
(Date:5/24/2013)... Frontiers, one of the world,s largest and fastest growing ... journal, Frontiers in Physics . , A broad ... will provide an open-science and interactive web platform ... rigorously peer-reviewed articles. , Frontiers, real-time and interactive ... range of article types. With an average of three ...
(Date:5/24/2013)... After studying noise in one French Quarter neighborhood ... levels exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor ... and Eric Arriaga, a third-year LSUHSC doctor of audiology ... their own hearing health. Their case study is published ... Hearing Practice Management ., "An important part of an ...
(Date:5/23/2013)... be the world,s most popular fruit, can be made ... purple GM varieties. , "Working with GM tomatoes ... addition of a specific compound, allows us to pinpoint ... Cathie Martin from the John Innes Centre. , The ... flavour, health and shelf life characteristics because even higher ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2... have discovered that chickens raised for meat can choose ... towards themselves or their eggs. , That phenomenon of ... figure out how to deal with less productive hens ... own bodies. "They like to be a little bit ...
... of Michigan State University researchers will use a $4 ... the functions of genes in a plant - research ... and agriculture. , In a collaborative effort spanning several ... 4,400 nuclear genes from the Arabidopsis plant. Arabidopsis is ...
... regulates the body's main biological clocks also may play ... Southwestern Medical Center have found. , The Clock gene ... and wakefulness, body temperature, hormone levels, blood pressure and ... of the brain's reward system. , UT Southwestern researchers ...
Cached Biology News:What comes first…the chicken, the egg, or the bad attitude? 2MSU researchers receive $4 million grant to uncover gene functions 2Gene controlling circadian rhythms linked to drug addiction 2TLN2 Antibody...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
...
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |